News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
217–252
Matches
36995
Sources here
22
Companies here
32
Search results Stored financial headlines

Active search

36995 matching headlines

Ticker or company: LTMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Energy Vault (NYSE: NRGV) lands $137.5M loan for power gear

Energy Vault Holdings, Inc. (NRGV) subsidiaries secured a $137.5 million senior secured term loan facility to fund the purchase and installation of power generation equipment. The loan, which matures on January 2, 2028, carries interest rates varying between 5.75% and 7.50% depending on the …

NRGV main company
Sharemaestro market context Price below Trend Line 52 weeks +131.1% NRGV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Delta Air Lines Inc. stock outperforms competitors despite losses on the day

Delta Air Lines Inc. (DAL) shares fell by 2.68% to $81.06 on Thursday, marking its fifth consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index (SPX) dropped 0.87% and the Dow Jones Industrial Average …

DELTA main company DAL main company
Sharemaestro market context Trend signal ended 52 weeks +79.2% DELTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HCA Healthcare, Inc. to Present at September Conferences

HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at two healthcare conferences in September 2026: the Wells Fargo Healthcare Conference on September 9 and the Jefferies Healthcare Conference on September 15. Live audio webcasts and presentation materials will be available on the Investor …

HCA main company H1CA34 main company HCA main company
Sharemaestro market context Price below Trend Line 52 weeks -4.1% · Next-week setup negative 35.6% HCA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Polyrizon (PLRZ) lines up sites for 120-patient allergy study

Polyrizon Ltd. (PLRZ) has finalized contracting with all five U.S. clinical sites for its 120-patient "first-in-human" study of NASARIX™ Allergy Blocker (PL-14), marking a significant operational milestone. The prospective, multicenter, randomized trial will evaluate NASARIX™ against isotonic saline nasal spray in patients with seasonal …

PLRZ main company
Sharemaestro market context Price below Trend Line 52 weeks +69.4% PLRZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IREN (IREN) Stock Looks Pricey Even After Its AI Pivot

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. IREN's share price has delivered a very large 3 year gain, yet the current …

IREN main company
Sharemaestro market context Price below Trend Line 52 weeks +105.6% IREN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aveanna Healthcare stock falls on 15M share secondary offering By Investing.com

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares dropped 9.2% in after-hours trading following the announcement of a secondary offering of 15 million shares by certain selling stockholders. Aveanna itself will not offer any shares or receive proceeds from this sale, with all net proceeds going …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% AVAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aveanna Announces Launch of Secondary Offering of Common Stock

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that certain selling stockholders are commencing a secondary offering of 15,000,000 shares of its common stock, with an option for an additional 2,250,000 shares. The company itself is not selling any shares and will not receive any …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% AVAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx scores FDA approval for gene therapy made at Bedford facility

Ultragenyx has received FDA approval for a new gene therapy that targets the root cause of glycogen storage disease type Ia. The therapy is manufactured at the company's facilities in Bedford, Massachusetts. Ultragenyx has a significant operational presence in Bedford, Somerville, and Woburn.

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hims & Hers (NYSE: HIMS) policy chief sells shares under 10b5-1 plan

Deborah M. Autor, Chief Policy Officer and a director at Hims & Hers Health, Inc. (HIMS), sold 16,773 shares of Class A Common Stock at $27.85 per share on August 18, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted …

HIMS main company
Sharemaestro market context Trend signal active 52 weeks -36.8% HIMS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Mobile Q2 2026 slides: EngageLab ARR surges 170%, revenue tops RMB 100M

Aurora Mobile Limited reported strong Q2 2026 earnings, with total revenue exceeding RMB 100 million for the third time and achieving its fifth consecutive quarter of US GAAP profitability. The growth was primarily driven by its EngageLab customer engagement platform, which saw its Annual …

JG main company
Sharemaestro market context Price below Trend Line 52 weeks -44.8% · Next-week setup negative 38.8% JG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

agilon health to Participate in Upcoming Conferences

WESTERVILLE, Ohio, August 20, 2026--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the following conferences: Wells Fargo 21st Annual Healthcare Conference …

AGL main company
Sharemaestro market context Trend signal active 52 weeks +191.4% · Next-week setup positive 57.8% AGL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alibaba Falls as AI Spending Surges 75% and Profit Misses

This article first appeared on GuruFocus. Alibaba Group (NYSE:BABA), China's e-commerce and cloud-computing powerhouse, fell to $127.01 Thursday after earnings delivered exactly the tension investors did not want: AI growth is ripping, but the bill is getting enormous. Adjusted earnings landed at 8.52 yuan …

BABA main company
Sharemaestro market context Price below Trend Line 52 weeks +1.6% BABA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Essent Group (NYSE: ESNT) CEO sells shares in 10b5-1 plan trades

Essent Group Ltd.'s Chairman, CEO, and President, Mark Casale, reported the sale of 41,853 common shares through a Rule 10b5-1 trading plan. The sales occurred on August 18 and August 19, 2026, at weighted average prices of $70.18 and $70.07 per share, respectively. This …

ESNT main company
Sharemaestro market context Trend signal active 52 weeks +11.3% ESNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Richardson Electronics (RELL) director to sell 1,500 shares

Richardson Electronics (RELL) director Kenneth Halverson has filed a notice to sell 1,500 shares of company common stock, valued at approximately $28,850. The shares were acquired as a stock award on January 29, 2024. The filing also indicates that Halverson previously sold 5,000 shares …

RELL main company
Sharemaestro market context Trend signal active 52 weeks +105.8% RELL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What We Missed: Delta Flight Disrupted With Wi-Fi Hack

Dark Reading editors discuss a Delta Air Lines flight from Las Vegas that was disrupted when a passenger created a fake Wi-Fi network, "Delta WiFi Fast," potentially leading to a phishing page. They also cover academic research demonstrating how a small hardware implant could …

DAL main company
Sharemaestro market context Trend signal active 52 weeks +46.1% · Next-week setup positive 55.4% DAL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Delta Is Quietly Cutting Its Las Vegas Routes To Rebuild The Hub Around Premium Flyers

Delta Air Lines has strategically cut several Las Vegas routes, including nonstop service from Sacramento and San Jose, to focus on higher-yield premium flyers. This move, driven by a 7% decline in Las Vegas tourism in early 2025 and a desire to avoid competing …

DAL main company
Sharemaestro market context Trend signal active 52 weeks +46.1% · Next-week setup positive 55.4% DAL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Americold’s Secret to Surviving Power Outages

Ever wondered how cold storage facilities protect vital goods during a major power outage? Brian Dunn, SVP of Facilities & Engineering and Head of Sustainability at Americold, reveals the incredible engineering and strategic planning that allows their warehouses to maintain sub-zero temperatures for up …

COLD main company
Sharemaestro market context Trend signal active 52 weeks +5.2% · Next-week setup negative 44.2% COLD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veralto to acquire Cleanwater1

Veralto is set to acquire Cleanwater1 for approximately $452 million to bolster its water treatment offerings. Cleanwater1 specializes in on-site hypochlorite disinfection, solids management, and odor filtration, with about 25,000 installed units. This acquisition will expand Veralto's presence in high-growth water treatment applications and …

VLTO main company
Sharemaestro market context Price above Trend Line 52 weeks -10.2% · Next-week setup positive 55.5% VLTO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease

Ultragenyx Pharmaceutical's gene therapy, Genglycos, has received accelerated FDA approval as the first treatment for glycogen storage disease type Ia (GSDIa). This one-time treatment addresses the root cause of the ultra-rare inherited enzyme deficiency, which previously required patients to consume raw cornstarch frequently. The …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $58.00

Citigroup has raised its price target for Ultragenyx Pharmaceutical (NASDAQ:RARE) to $58.00 from $45.00, maintaining a "buy" rating and suggesting a nearly 129% upside. This follows positive sentiment around the FDA approval of GENGLYCOS, Ultragenyx’s fifth approved product, which analysts believe will create significant …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Transocean Secures $300 Million Deepwater Drilling Deal with India's ONGC

Transocean Ltd. has secured a two-year, $300 million deepwater drilling contract with India's ONGC for its Dhirubhai Deepwater KG2 drillship, with operations beginning in Q1 2027. The deal includes options for extensions through 2031 and has positively impacted Transocean's stock, which rose 3% following …

RIG main company
Sharemaestro market context Price below Trend Line 52 weeks +89.5% · Next-week setup negative 42.3% RIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Mobile Ltd (JG) (Q2 2026) Earnings Call Highlights: SaaS Revenue Surpasses RMB100 Million with EngageLab ARR Soaring 170%

Aurora Mobile Ltd (JG) reported its Q2 2026 earnings, achieving its fifth consecutive quarter of US GAAP profitability with SaaS business revenue exceeding RMB100 million, a 13% year-over-year increase. The company's global flagship product, EngageLab, saw its Annual Recurring Revenue (ARR) surge by 170% …

JG main company
Sharemaestro market context Price below Trend Line 52 weeks -44.8% · Next-week setup negative 38.8% JG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context